Trending
Company Overview

Arsenal Biosciences

Sector: Healthcare

Arsenal Biosciences is a biotechnology company focused on developing engineered cell therapies, particularly in the field of cancer treatment. The company works on advancing next-generation therapeutic platforms designed to improve how immune cells target solid tumors and other difficult-to-treat diseases. Its operations center on research, clinical development, biotechnology engineering, and translating scientific innovation into precision immunotherapy products.

We are tracking 1 layoff event for Arsenal Biosciences as of Dec 14, 2025.

Key Metrics
0
Total Employees Affected
1
Layoff Events
50%
Avg. Percentage
Layoff Timeline
Dec 2025
Layoff History
December 14, 2025

The cell therapy biotech has laid off 50% of its staff as it restructures itself as a clinical-stage company.

Other Layoffs